Brussels: On Nov 9, the European Union drugs regulator is all ready to approve the use of two monoclonal antibodies to deal with COVID-19 patients in near future. The immediate decision came as the bloc encounters a new surge in infections and hospitalization even with high vaccination in many countries. Both medications are presently used to treat COVID-19 patients at risk of developing a drastic infection.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Dozens of rockets fired from Lebanon: Israeli army

About 45 rockets were fired from Lebanon on Thursday, the Israeli army…

Two shipping companies suspend Red Sea travel

Two more major shipping firms are suspending passage through a Red Sea…

PM Shehbaz extends FAC exemption to 300 units

Prime Minister Shehbaz Sharif on Thursday extended the exemption for fuel adjustment…